HOUSE OF REPRESENTATIVES

THE THIRTIETH LEGISLATURE

REGULAR SESSION OF 2019

 

COMMITTEE ON HEALTH

Rep. John M. Mizuno, Chair

Rep. Bertrand Kobayashi, Vice Chair

 

Rep. Della Au Belatti

Rep. Calvin K.Y. Say

Rep. Nadine K. Nakamura

Rep. James Kunane Tokioka

Rep. Joy A. San Buenaventura

Rep. Gene Ward

 

NOTICE OF HEARING

 

DATE:

Tuesday, March 19, 2019

TIME:

10:00 am

PLACE:

Conference Room 329

State Capitol

415 South Beretania Street

 

 

A G E N D A

 

SB 203

(SSCR758)

Status

RELATING TO VACCINATIONS.

Clarifies that pharmacists may perform certain vaccinations or immunizations and are required to maintain immunization records.

 

HLT, CPC

SB 366, SD2

Proposed HD1

Status

RELATING TO HEALTH.

Proposed HD1:  Appropriates funds for the Alzheimer's Disease and Related Dementia Services Coordinator position within the Executive Office on Aging.  Establishes Program Specialist IV position in the Chronic Disease Prevention and Health Promotion Division.  Effective 7/1/2050. (SD2) HD1 PROPOSED

 

Copies of the proposed HD1 are available in room 402 and on the Legislature's Web site:  http://www.capitol.hawaii.gov.

 

 

HLT, FIN

SB 911, SD1

(SSCR1087)

Status

RELATING TO HEALTH.

Appropriates funds to improve health care services related to cardiac care at Hilo Medical Center.  Effective 7/1/2050.  (SD1)

 

HLT, FIN

SB 1328

(SSCR767)

Status

RELATING TO PRESCRIPTION DRUGS.

Requires that if a proposed increase in the wholesale price of certain drugs would result in a 16% or more price increase over a 2‑year period, the drug manufacturer shall notify various drug insurance providers.

 

HLT, CPC

SB 1486, SD1

(SSCR910)

Status

RELATING TO ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM.

Allows the Department of Public Safety Narcotics Enforcement Division Administrator to disclose, at the Administrator's discretion, confidential information from the Electronic Prescription Accountability System, more commonly known as the Prescription Drug Monitoring Program, to authorized employees of the State of Hawaii Department of Health Alcohol and Drug Abuse Division and the Emergency Medical Services and Injury Prevention Systems Branch.  (SD1)

 

HLT, JUD

 

 

 

 

 

DECISION MAKING TO FOLLOW

 

Persons wishing to offer comments should submit testimony at least 24 hours prior to the hearing.  Testimony should indicate:

·    Testifier's name with position/title and organization;

·    The Committee(s) to which the comments are directed;

·    The date and time of the hearing; and

·    Measure number. 

 

While every effort will be made to incorporate all testimony received, materials received on the day of the hearing or improperly identified or directed, may be distributed to the Committee after the hearing.

 

Submit testimony in ONE of the following ways:

PAPER: 10 copies (including an original) to Room 403 in the State Capitol;

FAX:     For testimony less than 5 pages in length, transmit to 808-586-6311 (Oahu) or 1-800-535-3859 (for Neighbor Islander without a computer to submit testimony through e-mail or the Web); or

WEB:    For testimony less than 20MB in size, transmit from http://www.capitol.hawaii.gov/submittestimony.aspx.

 

Testimony submitted will be placed on the legislative website.  This public posting of testimony on the website should be considered when including personal information in your testimony.

 

If you require special assistance or auxiliary aids and/or services to participate in the House public hearing process (i.e., sign or foreign language interpreter or wheelchair accessibility), please contact the Committee Clerk at 586-6050 or email your request for an interpreter to HouseInterpreter@Capitol.hawaii.gov at least 24 hours prior to the hearing for arrangements.  Prompt requests submitted help to ensure the availability of qualified individuals and appropriate accommodations.

 

 

 

 

 

 

________________________________________

Rep. John M. Mizuno

Chair